- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa strikes DR deal with Canon Medical
Agfa strikes DR deal with Canon MedicalAgfa Medical Systems passed up the opportunity to add digital radiography to its product line when it bought Sterling Diagnostics last year but let Sterling’s subsidiary, Direct Radiography Corp., go
Agfa strikes DR deal with Canon Medical
Agfa Medical Systems passed up the opportunity to add digital radiography to its product line when it bought Sterling Diagnostics last year but let Sterlings subsidiary, Direct Radiography Corp., go (
PNN
2/99). Now the Belgium-based manufacturer of analog film, PACS, and CR will add Canons DR-Thorax system to its family of products. The open-ended agreement, which enables Agfa to market the DR-Thorax system in every country except Japan, will last at least three years and could be the beginning of a broader marketing and distribution relationship between the two companies.
In related news, Agfa signed an agreement with ALI Technologies of Vancouver, BC, whereby ALI will offer Agfa CR and hard-copy image systems with ALIs UltraPACS.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
